Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$1.36B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$236M |
| 3 |
Apple
AAPL
|
+$223M |
| 4 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$222M |
| 5 |
Southern Company
SO
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FON
SPRINT CORP FON COM
FON
|
+$724M |
| 2 |
Pfizer
PFE
|
+$469M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$409M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$407M |
| 5 |
Zoetis
ZTS
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.63% |
| 2 | Healthcare | 4.25% |
| 3 | Technology | 4.18% |
| 4 | Energy | 3.42% |
| 5 | Communication Services | 3.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KRA
4126
DELISTED
Kraton Corporation
KRA
| $460K | ﹤0.01% |
24,235
+1,391
| +6% | +$27.8K |
|
|
HF
4127
DELISTED
HFF Inc.
HF
| $460K | ﹤0.01% |
19,615
-7,679
| -28% | -$157K |
|
|
FNSR
4128
PUT
DELISTED
Finisar Corp
FNSR
| $460K | ﹤0.01% |
20,900
-19,000
| -48% | -$392K |
|
|
SGEN
4129
DELISTED
Seagen Inc. Common Stock
SGEN
| $459K | ﹤0.01% |
10,678
-72,505
| -87% | -$3.02M |
|
|
PNG
4130
DELISTED
PAA NATURAL GAS STORAGE, L.P. COM UNIT LTD PARTNERSHIP
PNG
| $459K | ﹤0.01% |
19,969
-1,020
| -5% | -$22.3K |
|
4131
PUT
Rambus
RMBS
$11B
| $458K | ﹤0.01% |
50,900
+20,300
| +66% | +$186K |
|
|
NVO
4132
CALL
Novo Nordisk
NVO
$209B
| $456K | ﹤0.01% |
27,000
-64,000
| -70% | -$1.08M |
|
4133
iShares MSCI Australia ETF
EWA
$1.45B
| $455K | ﹤0.01% |
18,200
-10,900
| -37% | -$262K |
|
4134
Pinnacle Financial Partners Inc
PNFP
$15.8B
| $455K | ﹤0.01% |
15,675
-7,262
| -32% | -$207K |
|
|
TFCF
4135
PUT
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $455K | ﹤0.01% |
+13,800
| New | +$435K |
|
|
EMBJ
4136
PUT
Embraer S.A. ADS
EMBJ
$13B
| $454K | ﹤0.01% |
14,200
+8,200
| +137% | +$285K |
|
4137
PUT
McCormick & Company Non-Voting
MKC
$14.2B
| $454K | ﹤0.01% |
14,200
-2,600
| -15% | -$91.2K |
|
4138
PUT
Parker-Hannifin
PH
$135B
| $454K | ﹤0.01% |
4,200
-31,800
| -88% | -$3.27M |
|
|
FINL
4139
CALL
DELISTED
Finish Line
FINL
| $454K | ﹤0.01% |
18,900
+5,700
| +43% | +$126K |
|
|
ROSE
4140
CALL
DELISTED
ROSETTA RESOURCES INC
ROSE
| $454K | ﹤0.01% |
8,400
-8,100
| -49% | -$383K |
|
|
LORL
4141
DELISTED
Loral Space and Communications, Inc.
LORL
| $453K | ﹤0.01% |
6,754
-699
| -9% | -$45.3K |
|
|
CSR
4142
Centerspace
CSR
$952M
| $452K | ﹤0.01% |
5,649
+1,596
| +39% | +$136K |
|
4143
Myers Industries
MYE
$1.29B
| $451K | ﹤0.01% |
22,508
-13,904
| -38% | -$259K |
|
|
ANK
4144
DELISTED
ATLANTIC TELE-NETWORK,INC
ANK
| $451K | ﹤0.01% |
8,667
-1,329
| -13% | -$69.2K |
|
4145
CALL
EnerSys
ENS
$6.99B
| $450K | ﹤0.01% |
7,500
+700
| +10% | +$37.6K |
|
4146
Harmonic Inc
HLIT
$1.28B
| $450K | ﹤0.01% |
64,268
-38,198
| -37% | -$283K |
|
4147
VanEck High Yield Muni ETF
HYD
$4.45B
| $450K | ﹤0.01% |
7,762
+217
| +3% | +$12.7K |
|
4148
CALL
Pediatrix Medical
MD
$2.2B
| $450K | ﹤0.01% |
9,000
+6,800
| +309% | +$332K |
|
4149
PUT
Medifast
MED
$141M
| $450K | ﹤0.01% |
17,300
+11,400
| +193% | +$305K |
|
|
MTOR
4150
CALL
DELISTED
MERITOR, Inc.
MTOR
| $450K | ﹤0.01% |
64,300
+40,100
| +166% | +$310K |
|
Similar funds
Barclays's Q3 2013 Portfolio in Review
As of Q3 2013, Barclays held 8,017 positions worth $83.8B, up 4.2% from $80.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays's Q3 2013 filing shows 302 new, 3,328 increased, 3,470 reduced and 580 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M. The largest sale was SPRINT CORP FON COM, an estimated $724M.
By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 4.5% a quarter earlier, followed by Healthcare and Technology.
- Barclays's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M.
- Barclays added most to iPath ETNs Linked to the MSCI India Total Return Index in Q3 2013, an estimated $1.36B increase.
- Barclays's biggest Q3 2013 reduction was Pfizer, cutting an estimated $469M.
- Barclays fully exited SPRINT CORP FON COM in Q3 2013, selling an estimated $724M.
- Barclays's ten largest holdings make up 26% of its $83.8B portfolio in Q3 2013.
- Barclays opened 302 new positions and closed 580 in Q3 2013.
- Barclays's portfolio value rose 4.2% quarter-over-quarter to $83.8B.
Based on Barclays's 13F filing for Q3 2013, filed 14 Nov 2013.